Patterns of spironolactone management following hyperkalemia among hospitalized patients with heart failure and reduced ejection fraction: a retrospective single-center study
Background Heart failure with reduced ejection fraction (HFrEF) is a major cause of morbidity and mortality worldwide. Hyperkalemia is a common complication of chronic spironolactone therapy and may necessitate dose reduction or discontinuation, particularly in patients with impaired renal function. This study aimed to...